Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 279-291, 2023.
Article in English | WPRIM | ID: wpr-982699

ABSTRACT

Oxidative stress plays a crucial role in cadmium (Cd)-induced myocardial injury. Mitsugumin 53 (MG53) and its mediated reperfusion injury salvage kinase (RISK) pathway have been demonstrated to be closely related to myocardial oxidative damage. Potentilla anserina L. polysaccharide (PAP) is a polysaccharide with antioxidant capacity, which exerts protective effect on Cd-induced damage. However, it remains unknown whether PAP can prevent and treat Cd-induced cardiomyocyte damages. The present study was desgined to explore the effect of PAP on Cd-induced damage in H9c2 cells based on MG53 and the mediated RISK pathway. For in vitro evaluation, cell viability and apoptosis rate were analyzed by CCK-8 assay and flow cytometry, respectively. Furthermore, oxidative stress was assessed by 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) staining and using superoxide dismutase (SOD), catalase (CAT), and glutathione/oxidized glutathione (GSH/GSSG) kits. The mitochondrial function was measured by JC-10 staining and ATP detection assay. Western blot was performed to detect the expression of proteins related to MG53, the RISK pathway, and apoptosis. The results indicated that Cd increased the levels of reactive oxygen species (ROS) in H9c2 cells. Cd decreased the activities of SOD and CAT and the ratio of GSH/GSSG, resulting in decreases in cell viability and increases in apoptosis. Interestingly, PAP reversed Cd-induced oxidative stress and cell apoptosis. Meanwhile, Cd reduced the expression of MG53 in H9c2 cells and inhibited the RISK pathway, which was mediated by decreasing the ratio of p-AktSer473/Akt, p-GSK3βSer9/GSK3β and p-ERK1/2/ERK1/2. In addition, Cd impaired mitochondrial function, which involved a reduction in ATP content and mitochondrial membrane potential (MMP), and an increase in the ratio of Bax/Bcl-2, cytoplasmic cytochrome c/mitochondrial cytochrome c, and Cleaved-Caspase 3/Pro-Caspase 3. Importantly, PAP alleviated Cd-induced MG53 reduction, activated the RISK pathway, and reduced mitochondrial damage. Interestingly, knockdown of MG53 or inhibition of the RISK pathway attenuated the protective effect of PAP in Cd-induced H9c2 cells. In sum, PAP reduces Cd-induced damage in H9c2 cells, which is mediated by increasing MG53 expression and activating the RISK pathway.


Subject(s)
Cadmium/metabolism , Caspase 3/metabolism , Potentilla/metabolism , Glycogen Synthase Kinase 3 beta/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Cytochromes c/metabolism , Glutathione Disulfide/pharmacology , Oxidative Stress , Myocytes, Cardiac , Reactive Oxygen Species/metabolism , Reperfusion Injury/metabolism , Apoptosis , Polysaccharides/pharmacology , Adenosine Triphosphate/metabolism
2.
Indian J Biochem Biophys ; 1998 Jun; 35(3): 157-60
Article in English | IMSEAR | ID: sea-26736

ABSTRACT

Yeast glutathione reductase (GR) was inactivated by phenylglyoxal (PG), which specifically modifies arginine residues of the enzyme. Inactivation followed psuedo-first order rate kinetics. There was no reversible complex formation prior to inactivation. Analysis of the kinetic data showed the order of reaction to be unity with respect to the modifier. Inactivation of GR was completely prevented by the presence of oxidised glutathione (GSSG), whereas NADP gave only partial protection. Stoichiometric studies showed that around four arginine residues per subunit were modified by PG in the absence of GSSG, whereas only one was modified in its presence. From these observations, it is concluded that essential arginine residues are present at the substrate binding site.


Subject(s)
Arginine/metabolism , Binding Sites/physiology , Enzyme Inhibitors/pharmacology , Fungal Proteins/chemistry , Fungi/enzymology , Glutathione Disulfide/pharmacology , Glutathione Reductase/chemistry , Kinetics , NADP/pharmacology , Phenylglyoxal/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL